It’s time to change the treatment paradigm: HCV testing and treatment in community and low threshold settings

In cooperation with the Auto-Support des Usagers de Drogues (ASUD), Association Gaia and the European Network of People Who Use Drugs (EURONPUD), the Correlation Hepatitis C Initiative organises a seminar for community members, harm reduction workers, HCV researchers and activists engaged in HCV prevention, treatment and advocacy. The seminar’s aim is to provide insights in newest developments in HCV testing and treatment opportunities, to present good practices of community and harm reduction based HCV activities and to exchange and discuss future opportunities.

The second day will take place in a venue of the first drug consumption room (DCR) in France (to be opened in October), and will highlight the concept and approach of DCR’s and presenting results of a survey on hcv awareness in drug consumption rooms worldwide, carried out by SidneyMSIC and the Drug Consumption Room Network.

Abstracts
There is the opportunity to include a small number of additional presentations to the programme. If you want to do so, please submit your abstract to eschatz@correlation-net.org before the 20th of September. Attendance costs of speakers can be covered on request.

Registration
Registration fee is 75 Euro.

For more information, visit the event's website.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

Thumbnail: Flickr CC Pasteur